biotech investors

Professor John Oxford offers scientific advice and analysis to financial investor groups wishing to invest in biotech companies.

Professor Oxford can direct investors towards biotech companies that offer, in his opinion, the greatest likelihood of success.


Alternatively, he can produce risk assessments of specific companies and products already of interest to investors.

To do this, Professor Oxford will look into:

  • the quality of the research and development already invested in the over-the-counter remedy, vaccine or anti-viral drug
  • expected regulatory approval time-frames
  • platform technology potential
  • similar drugs already in the market place; how that might affect consumer demand
  • track record of the company involved
  • clinical trial results